Fundraising Fox

Kernal Biologics

YC S20

Boston, US · 20 employees · 4 known investors

kernalbio.com

Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.

AI & Machine LearningBiotechHealthtechMedical DevicesArtificial IntelligenceGenomicsin /kernal-biologics-inc./@kernalbio

Founders & leadership· Y Combinator alumni (S20)

Yusuf Erkul
Yusuf Erkulin𝕏Chief Executive Officer & Cofounder
Jeff Ozdemir
Jeff OzdemirinHead of Platform & Cofounder
BY
Burak YilmazPresident & Cofounder

Investors · 4

In the news